Thomas E. Clancy

About

Thomas E. Clancy is a leading figure in pancreatic surgery, with research focused on advancing minimally invasive techniques and optimizing perioperative care for pancreatic cancer patients. His major contributions center on comparing outcomes across surgical approaches—open, laparoscopic, and robotic—for complex procedures like distal pancreatectomy and pancreatoduodenectomy (the Whipple procedure). His landmark 2017 study, with 76 citations, analyzed 1,815 patients from the ACS-NSQIP database to demonstrate the safety and efficacy of robotic and laparoscopic distal pancreatectomy versus open surgery. Clancy’s 2015 review on surgery for pancreatic cancer (72 citations) remains a key reference for treatment strategies. Most notably, his 2023 work on the "Four-Day Robotic Whipple" pioneered an enhanced recovery after surgery (ERAS) pathway enabling early discharge after robotic pancreatoduodenectomy, showing synergistic benefits of robotics and streamlined recovery protocols. With over 160 total citations across these works, Clancy has helped shape modern pancreatic surgery by providing evidence that robotic approaches can reduce hospital stays without compromising outcomes, advancing both surgical innovation and patient-centered care.

Research Focus

Key Achievements

Top Papers

1. 1
   Comparison of Perioperative Outcomes between Open, Laparoscopic, and Robotic Distal Pancreatectomy: an Analysis of 1815 Patients from the ACS-NSQIP Procedure-Targeted Pancreatectomy Database

   76 citations · 2017
2. 2
   Surgery for Pancreatic Cancer

   72 citations · 2015
3. 3
   Four-Day Robotic Whipple: Early Discharge after Robotic Pancreatoduodenectomy

   13 citations · 2023

Key Collaborators

Contact & Links